PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Quinine sulfate 300mg/5ml oral suspension
0504010Y0AABCBC
Quinine sulfate Quinine sulfate Infections 47
Levamisole 50mg tablets
0505020L0AAABAB
Levamisole hydrochloride Levamisole hydrochloride Infections 45
Pyrimethamine 25mg tablets
0504010N0AAAAAA
Pyrimethamine Pyrimethamine Infections 45
Benzylpenicillin sodium 600mg inj vials
0501011J0AAABAB
Benzylpenicillin sodium (Penicillin G) Benzylpenicillin sodium (Penicillin G) Infections 43
Ertapenem 1g powder for solution for infusion vials
0501022B0AAAAAA
Ertapenem sodium Ertapenem sodium Infections 43
Ampicillin 250mg capsules
0501013E0AAAAAA
Ampicillin Ampicillin Infections 42
Famvir 250mg tablets
0503021E0BBAAAA
Famvir Famciclovir Infections 42
Augmentin 125/31 oral suspension
0501013K0BBAPAH
Augmentin Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 40
Ciproxin 250mg/5ml oral suspension
0501120L0BBAJBG
Ciproxin Ciprofloxacin Infections 40
Albendazole 400mg chewable tablets
0505030A0AAABAB
Albendazole Albendazole Infections 39
Diflucan 50mg capsules
0502010B0BBAAAA
Diflucan Fluconazole Infections 38
Rifinah 150mg/100mg tablets
0501090S0BBAAAA
Rifinah Rifampicin combined preparations Infections 37
Distaclor MR 375mg tablets
0501021A0BBAEAG
Distaclor Cefaclor Infections 35
Ovex 100mg chewable tablets
0505010D0BCAAAD
Ovex Mebendazole Infections 35
Doxycycline 50mg/5ml oral solution
0501030I0AAAHAH
Doxycycline hyclate (Antibacterial) Doxycycline hyclate Infections 34
Ketoconazole 200mg tablets
0502020A0AAACAC
Ketoconazole (Systemic) Ketoconazole Infections 34
Neomycin 500mg tablets
0501040N0AAADAD
Neomycin sulfate (Systemic) Neomycin sulfate Infections 32
Sporanox-Pulse 100mg capsules
0502010C0BBABAA
Sporanox Itraconazole Infections 32
Tobramycin 300mg/4ml nebuliser liquid ampoules
0501040U0AAAKAK
Tobramycin (Systemic) Tobramycin Infections 32
Augmentin-Duo 400/57 oral suspension
0501013K0BBAQAP
Augmentin Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 30
Azithromycin 200mg/5ml oral suspension sugar free
0501050A0AAAHAH
Azithromycin Azithromycin Infections 30
Ivermectin 6mg tablets
0505060I0AAAEAE
Ivermectin Ivermectin Infections 30
Ovex 100mg/5ml oral suspension
0505010D0BCABAA
Ovex Mebendazole Infections 30
Amoxicillin 125mg/1.25ml oral suspension paediatric
0501013B0AAAIAI
Amoxicillin Amoxicillin Infections 29
Malarone Paediatric 62.5mg/25mg tablets
0504010U0BBABAB
Malarone Proguanil hydrochloride with atovaquone Infections 29

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.